HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martine Hofmann Selected Research

2- (2- oxo- 4- phenylpyrrolidin- 1- yl)acetamide

6/2015Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martine Hofmann Research Topics

Disease

2Pain (Aches)
11/2016 - 12/2012
1Neuralgia (Stump Neuralgia)
11/2016
1Hypersensitivity (Allergy)
11/2016
1Parkinson Disease (Parkinson's Disease)
06/2015
1Dyskinesias (Dyskinesia)
06/2015
1Hyperalgesia
12/2012

Drug/Important Bio-Agent (IBA)

1LipidsIBA
11/2016
1Telmisartan (Micardis)FDA Link
11/2016
1Cytostatic AgentsIBA
11/2016
1Paclitaxel (Taxol)FDA LinkGeneric
11/2016
1Protein Isoforms (Isoforms)IBA
11/2016
1Ion Channels (Ion Channel)IBA
11/2016
1Levodopa (L Dopa)FDA LinkGeneric
06/2015
1Dopamine (Intropin)FDA LinkGeneric
06/2015
12- (2- oxo- 4- phenylpyrrolidin- 1- yl)acetamideIBA
06/2015
1L 838,417IBA
12/2012
1gamma-Aminobutyric Acid (GABA)IBA
12/2012
1Formaldehyde (Formol)FDA Link
12/2012
13'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA
12/2012

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2016
1Therapeutics
11/2016
1Ligation
12/2012